Rights and permissions
About this article
Cite this article
Etoricoxib economically superior to nonselective NSAIDs in AS. Pharmacoecon. Outcomes News 486, 9 (2005). https://doi.org/10.2165/00151234-200504860-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504860-00022